Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1989 | 03-1989 | 12-1988 | 09-1988 | 06-1988 | |
| Sales | 160 | 80 | 560 | 583 | 503 |
| Cost of Goods | 177 | 415 | 447 | 443 | 262 |
| Gross Profit | -18 | -335 | 112 | 140 | 240 |
| Operating Expenses | 2,388 | 2,222 | 2,613 | 2,286 | 1,808 |
| Operating Income | -2,228 | -2,142 | -2,054 | -1,703 | -1,305 |
| Interest Expense | 63 | 62 | 61 | 63 | 62 |
| Other Income | 1,349 | 695 | 263 | 278 | 269 |
| Pre-tax Income | -942 | -1,510 | -1,852 | -1,488 | -1,098 |
| Income Tax | 7 | 0 | 7 | 0 | 0 |
| Net Income Continuous | -950 | -1,510 | -1,858 | -1,488 | -1,098 |
| Net Income | $-950 | $-1,510 | $-1,858 | $-1,488 | $-1,098 |
| EPS Basic Total Ops | N/A | N/A | -16.34 | N/A | -9.87 |
| EPS Basic Continuous Ops | N/A | N/A | -16.34 | N/A | -9.87 |
| EPS Diluted Total Ops | N/A | N/A | -16.34 | N/A | -9.87 |
| EPS Diluted Continuous Ops | N/A | N/A | -16.34 | N/A | -9.87 |
| EBITDA(a) | $-2,228 | $-2,142 | $-2,054 | $-1,703 | $-1,305 |